Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194
NCT00820170
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Dasatinib and Paclitaxel
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]